Granules India
GRANULES · Pharma > Pharmaceuticals & Drugs · Chairman: Krishna Prasad Chigurupati · MD: Krishna Prasad Chigurupati · Listing date: June 21, 2005 · Employees: 3369 · Hyderabad · http://www.granulesindia.com

Stock Price vs Company Growth
1d
1.6%
1w
3.3%
1m
1.3%
3m
2.5%
6m
30.0%
1y
41.0%
5y
30.7%
10y
30.5%
all
26.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 424 1.6%
382
480
Company Overview

Sales
4,526 Cr
Growth: 7.7%
Profit after Tax
395 Cr
Growth: 0.3%
Mid Cap
10,284 Cr
P/E: 26.0x
Industry P/E: 35.5x
Fundamentals

Sales (Cr) ₹ 4,526
Growth 7.7%
EBITDA 18.3%
P/S 2.3x
Dividend 0.5%
P/E 26.0x
Book Value ₹ 128
PEG Ratio 3.4x
ROE 13.4%
P/B 3.3x
Shareholding Pattern

Institutions
Government Pension Fund Global
3.01 %
Fidelity Funds - Asian Smaller Companies Pool
1.55 %
Mahima Stocks Private Limited
1.49 %
Basava Sankara Rao Kolli
1.21 %
Iepf
0.1 %
Promoters
Krishna Prasad Chigurupati
34.84 %
Chigurupati Uma Devi
3.82 %
Tyche Investments Private Limited
1.47 %
Chigurupati Pragnya
0.76 %
Chigurupati Priyanka
0.75 %
Others
Qualified Instituional Buyer
0.15 %
Increase    Decrease    No change
Company Profile Detailed

Granules India is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India today. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs).
Investors (106)
Followers (24)